| 证券代码 | ARA.N |
| 证券名称 | American Renal Associates Holdings Inc |
| 证券类型 | 美股 |
| 上市场所 | 纽约证券交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2016-04-21 |
| 首发价格(元) | 22 USD |
| 首发数量(股) | 7500000 |
| 首发募资额(元) | 165,000,000.00 USD |
| 首发主承销商 | Barclays Capital Inc,Goldman, Sachs & Co,Merrill Lynch, Pierce, |
| 货币单位 | USD |
| 公司名称 | American Renal Associates Holdings, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 500 Cummings Center, Beverly, Massachusetts, USA |
| 成立日期 | 2010-03-18 |
| 董事会主席 | Joseph A. Carlucci |
| 公司属地 | United States 美国 |
| 公司网址 | www.americanrenal.com |
| 电话 | +1 (978) 922-3080 |
| 传真 | +1 (978) 232-8411 |
| 公司简介 | American Renal Associates Holdings, Inc. (NYSE: ARA) is a leading provider of outpatient dialysis services in the United States. As of March 31, 2017, ARA operated 217 dialysis clinic locations in 25 states and the District of Columbia serving approximately 14,700 patients with end stage renal disease. ARA operates exclusively through a physician joint venture model, in which it partners with approximately 380 local nephrologists to develop, own and operate dialysis clinics. ARA’s Core Values emphasize taking good care of patients, providing physicians with clinical autonomy and operational support, hiring and retaining the best possible staff and providing best practices management services. |